Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Good. 284 pp., Hardcover, ex library, else text clean and binding tight. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Condition: Very Good. 286 pp., hardcover, ex library, but text and binding still clean and tight . - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
Language: English
Published by Kluwer Academic Publishers, 1994
ISBN 10: 0792388720 ISBN 13: 9780792388722
Cloth/Laminated Boards. Condition: Very Good. Type: Book The timing of toxicological studies in relation to the clinical evaluation of new medicines is a key topic for strategic planners in the industry and those involved with harmonization. Resolving the anomalies between different regulatory authorities should eliminate redundant testing on animals and improve the efficiency of the developmental process by encouraging single international strategies. To aid industry in reaching a consensus, the Centre for Medicines Research has brought together representatives of the pharmaceutical industry from Europe, Japan and the USA to give a comprehensive account of current international industry positions on the subject. The contributions in this text review the situation and address the clinical and strategic requirements of the pre-clinical programme. Personal and consensus proposals on the toxicity studies required to initiate clinical investigations, the timing of reproductive toxicity tests and the duration of repeat-dose studies to support clinical development are provided. Small mark at base of spine.128pp.
Language: English
Published by Centre for Medicines Research International, 1997
ISBN 10: 0952216914 ISBN 13: 9780952216919
Seller: Antiquariat Bücherkiste, Wuppertal, Germany
Broschiert. Condition: Sehr gut. S. DORABJEE / C.E. LUMLEY / S.R. WALKER The Effect of Corporate - Culture on the Success of Research and Development Broschiert - in Englisch - Centre for Medicines Research International - 53 Seiten - 1997 - ISBN 0952216914 Aus dem Inhalt: Can Culture be managed Pfizer Central Research und mehr Zustand: Ecken und Kanten außen leicht bestossen, sonst sehr gut! Size: 15 x 23 cm. Buch.
Seller: The Book Exchange, Macclesfield, CHESH, United Kingdom
Hardcover. Condition: Fine. No Jacket. 1856420736. A pictorial board ex lib. hardcover. Lending record shows this book has never been borrowed. 181 pages, index, appendix, illustrated with charts, tables and diagrams. Proceedings of a Workshop held at the Ciba Foundation, London, May 1991. Contents clean, tight and bright. Book.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 49.30
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Chiron Media, Wallingford, United Kingdom
Paperback. Condition: New.
Seller: Better World Books: West, Reno, NV, U.S.A.
Condition: Good. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 76.31
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: As New. Unread book in perfect condition.
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - For a research-based pharmaceutical company to be successful in the 1990s. it must have a strategic plan for the global development of new chemical entities. Global development can be defined as an attempt to reach all major markets as rapidly as possible and for many companies these will include the United States. Japan. Germany. France. Italy. UK and Canada. which together represent approximately 85% of the pharmaceutical market in the developed world. The mutual acceptance of foreign clinical data would reduce the time and resources required to develop a new medicine for the international market by eliminating the requirement for the routine repetition of clinical studies in local populations. In Japan this has been largely based on the belief that genetic differences in respon siveness may result in a different benefit/risk assessment for a new mediCine. while requests in Europe and the United States for local data relate mainly to methodological and cultural considerations. The importance of this issue has been recognised internationally as it was one of the topics discussed at the International Conference on Harmonisation in Orlando (October 1993) and it is currently on the programme for ICH3 which will be convened in Yokohama in Japan in November 1995.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 94.30
Quantity: Over 20 available
Add to basketCondition: New. In.
Taschenbuch. Condition: Neu. The Relevance of Ethnic Factors in the Clinical Evaluation of Medicines | Proceedings of a Workshop held at The Medical Society of London, UK, 7th and 8th July, 1993 | S. R. Walker (u. a.) | Taschenbuch | xviii | Englisch | 2012 | Springer | EAN 9789401046213 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 94.62
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New.
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New.
Paperback. Condition: Like New. Like New. book.
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
£ 105.47
Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
Language: English
Published by Kluwer Academic Publishers, 1995
ISBN 10: 0792388720 ISBN 13: 9780792388722
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. The timing of toxicological studies in relation to the clinical evaluation of new medicines is a key topic for strategic planners in the industry and those involved with harmonisation. This book reviews the situation and addresses the clinical and strategic requirements of the preclinical programme. Editor(s): Parkinson, C. Num Pages: 150 pages, biography. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 11. Weight in Grams: 930. . 1995. Hardback. . . . .
Hardcover. Condition: Brand New. 1st edition. 262 pages. 9.75x6.50x1.00 inches. In Stock.
Language: English
Published by Springer Netherlands|Springer, Berlin, 1994
ISBN 10: 0792388437 ISBN 13: 9780792388432
Seller: moluna, Greven, Germany
Condition: New. There is currently limited acceptance of foreign clinical data by regulatory authorities, although the reasons for repeating studies are poorly defined. There are some proven genetic differences in drug metabolism and elimination which occur with varying fr.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - There is currently limited acceptance of foreign clinical data by regulatory authorities, although the reasons for repeating studies are poorly defined. There are some proven genetic differences in drug metabolism and elimination which occur with varying frequencies in different populations. In addition, there are differences in culture, environment and medical practice which can impact on drug reponsiveness. This book, a further edition in the CMR Workshop Series, reviews the proceedings of a workshop held in London in July 1993 to address these issues. The contributors review the current situation, address the scientific basis for repeating clinical trials in different ethnic groups, consider specific examples, and assess the relevance of interethnic and environmental differences in responsiveness for drug development.
Seller: Revaluation Books, Exeter, United Kingdom
Paperback. Condition: Brand New. 172 pages. 9.25x6.10x0.39 inches. In Stock.
Taschenbuch. Condition: Neu. The Timing of Toxicological Studies to Support Clinical Trials | C. Parkinson (u. a.) | Taschenbuch | xvi | Englisch | 2012 | Springer | EAN 9789401046237 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 134.30
Quantity: Over 20 available
Add to basketCondition: New. In.
Seller: Ria Christie Collections, Uxbridge, United Kingdom
£ 134.30
Quantity: Over 20 available
Add to basketCondition: New. In.
Language: English
Published by Kluwer Academic Publishers, 1995
ISBN 10: 0792388720 ISBN 13: 9780792388722
Seller: Kennys Bookstore, Olney, MD, U.S.A.
Condition: New. The timing of toxicological studies in relation to the clinical evaluation of new medicines is a key topic for strategic planners in the industry and those involved with harmonisation. This book reviews the situation and addresses the clinical and strategic requirements of the preclinical programme. Editor(s): Parkinson, C. Num Pages: 150 pages, biography. BIC Classification: MMG; TDCW. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 11. Weight in Grams: 930. . 1995. Hardback. . . . . Books ship from the US and Ireland.
Language: English
Published by Springer Netherlands, 1995
ISBN 10: 0792388720 ISBN 13: 9780792388722
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for r.
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the past twelve years, the Centre for Medicines Research has held a series of Workshops on a number of topics related to the drug discovery and development process. The major objective of these Workshops has been to provide an international forum for regula tory, academic and industry representatives to debate together, and suggest solutions to, specific problems. The meeting reported in this volume represents a departure from this approach, in that the par ticipants were drawn largely from the pharmaceutical industry. Senior clinicians, pharmacologists and toxicologists from companies in Europe, the USA and Japan met in May 1994 to discuss a scientific rationale for the conduct of toxicity studies to support the clinical development of new medicines, and to begin to work towards an industry consensus. Achievement of such a consensus is seen as an important step in the process leading towards international harmon isation of the recommendations on the timing of toxicity studies in relation to clinical trials.